Navigation Links
Bionovo Receives Positive Guidance from FDA on Menerba®
Date:8/30/2010

early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets. Bionovo is headquartered in Emeryville, California and is traded on the NASDAQ Capital Market under the symbol, "BNVI". For more information about Bionovo and its programs, visit http://www.bionovo.com.

Forward Looking Statements

This release contains certain forward-looking statements relating to the business of Bionovo, Inc. that can be identified by the use of forward-looking terminology such as "believes," "expects," or similar expressions. Such forward-looking statements involve known and unknown risks and uncertainties, including uncertainties relating to product development, efficacy and safety, regulatory actions or delays, the ability to obtain or maintain patent or other proprietary intellectual property protection, market acceptance, physician acceptance, third party reimbursement, future capital requirements, competition in general and other factors that may cause actual results to be materially different from those described herein as anticipated, believed, estimated or expected. Certain of these risks and uncertainties are or will be described in greater detail in our filings with the Securities and Exchange Commission, which are available at http://www.sec.gov. Bionovo, Inc. is under no obligation (and expressly disclaims any such obligation) to update or alter its forward-looking statements whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Bionovo, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bionovo Announces Reverse Stock Split
2. Bionovo Announces Publication Describing Menerbas Effect on Neural Pathways Related to Temperature Regulation
3. Bionovo to Advance Menerba to Phase 3 Clinical Testing in Europe
4. Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
5. Bionovo Announces a $15 Million At-The-Market Firm Commitment Financing Agreement
6. Bionovo Announces 2009 Highlights and Year-End Financial Results
7. Bionovo, Inc. to Announce Fourth Quarter and Fiscal Year 2009 Financial Results on Monday, March 15, 2010
8. Bionovo Announces Publication of Positive Results From the Phase 1B Clinical Trial of Bezielle (BZL101) for Metastatic Breast Cancer
9. Bionovo Announces Third Quarter 2009 Highlights and Financial Results
10. Bionovo, Inc. to Announce Third Quarter Fiscal Year 2009 Financial Results on Thursday, November 5, 2009
11. Bionovo Announces Publication of Data on Potential Increase in Breast Cancer Risk Due to the Inhibitory Effect of Tamoxifen Treatment on Estrogen Receptor Beta
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... Aug. 3, 2015  Landauer, Inc. (NYSE: LDR ... measurement and monitoring, outsourced medical physics services and high ... financial results for the fiscal third quarter 2015 after ... The Company will also host a conference ... 9:00 a.m. Central Time (10:00 a.m. Eastern Time). Investors ...
(Date:8/3/2015)... MINNEAPOLIS , Aug. 3, 2015 /PRNewswire/ ... a significant shareholder and will become the exclusive ... for cardiology-related diagnostic and monitoring offerings. ... for Preventice Solutions," said Jon Otterstatter , ... Preventice Solutions.  "We are thrilled to partner with ...
(Date:8/3/2015)... Pharmacy, Inc. (NYSE: DPLO ), the nation,s largest independent ... 30, 2015. All comparisons, unless otherwise noted, are to the ... 2015 Highlights include: , Revenue of $808 million, ... prescriptions dispensed of 234,000, an increase of 19% , ... of $22.7 million, an increase of 287% or $16.8 million ...
Breaking Medicine Technology:Landauer, Inc. Announces Date And Time For Announcement Of Fiscal Third Quarter 2015 Results And Conference Call 2Boston Scientific Announces Equity Investment And Sales Cooperation Agreement With Preventice Solutions 2Diplomat Announces 2nd Quarter 2015 Financial Results 2Diplomat Announces 2nd Quarter 2015 Financial Results 3Diplomat Announces 2nd Quarter 2015 Financial Results 4Diplomat Announces 2nd Quarter 2015 Financial Results 5Diplomat Announces 2nd Quarter 2015 Financial Results 6Diplomat Announces 2nd Quarter 2015 Financial Results 7Diplomat Announces 2nd Quarter 2015 Financial Results 8Diplomat Announces 2nd Quarter 2015 Financial Results 9Diplomat Announces 2nd Quarter 2015 Financial Results 10Diplomat Announces 2nd Quarter 2015 Financial Results 11Diplomat Announces 2nd Quarter 2015 Financial Results 12Diplomat Announces 2nd Quarter 2015 Financial Results 13Diplomat Announces 2nd Quarter 2015 Financial Results 14Diplomat Announces 2nd Quarter 2015 Financial Results 15Diplomat Announces 2nd Quarter 2015 Financial Results 16Diplomat Announces 2nd Quarter 2015 Financial Results 17Diplomat Announces 2nd Quarter 2015 Financial Results 18
... Nobilon, the human vaccine business unit of ... that it has reached an important milestone with the ... 900795, a new intranasal Live Attenuated Influenza Vaccine (LAIV) ... the three attenuated Influenza viruses recommended by the World ...
... Texas, March 13 At the Health Industries Council ... and professor of public health and behavioral sciences at ... School of Public Health, announced new findings that ... Specifically, unemployment and reduced spending on health care ...
Cached Medicine Technology:Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development 2Nobilon Advances First Vaccine Into Human Trials - Intranasal Influenza Vaccine Begins Phase I Clinical Development 3Unemployment, Health Care Spending Affect Mortality 2
(Date:8/3/2015)... ... ... They know every second counts. And when it comes to stroke, the ... best care in the nation. For the past two months, the stroke team led ... time in the country. During the months of June and July, it took the ...
(Date:8/3/2015)... ... 03, 2015 , ... Kantor & Kantor, LLP announced today ... client Rebecca Hamsher, deciding that in accordance with ERISA ( Employee Retirement Income ... treatment for bulimia, depression and other mental health problems. , According to the ...
(Date:8/3/2015)... ... 03, 2015 , ... Pitt Researchers to Monitor Resistance to ... School of Medicine are leading a five-year, $5 million initiative to monitor drug ... A cooperative agreement awarded by the U.S. Agency for International Development (USAID), will ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... Seattle-based Genelex to offer pharmacogenetic lab testing and precision medicine solutions that can ... costs. , Annually, more than 8.6 million adverse drug events are reported ...
(Date:8/3/2015)... ... August 03, 2015 , ... Catalent ... for drugs, biologics and consumer health products, today welcomed the announcement by OPKO ... New Drug Application for a new treatment for chronic kidney disease (CKD) and ...
Breaking Medicine News(10 mins):Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 2Health News:Providence St. Vincent Stroke Care Recognized Among Best in the Country 3Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 2Health News:Kantor & Kantor Announces North Cypress Medical Center Must Reimburse Benefits for Mental Health Treatment 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 2Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 3Health News:$5M Effort to Guide Use of HIV Prevention Meds in Africa 4Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 2Health News:Novation Awards Genelex First Group Purchasing Agreement for Pharmacogenetic Testing and Precision Medicine Software 3Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3
... developed a new method that advocates the use of ... ,D. Karunagaran, a professor at the department of ... Madras, and Suby Oommen, a PhD student at the ... working on garlic-based components and their effects on cancer ...
... Pakistani government has strictly warned health officials in Islamabad not ... thirty five deaths// following viral dengue fever in ... department of Health divulged to media that the health ... nurse from sharing or divulging any news related to the ...
... issue of Developmental Psychology has explained the immense benefit ... // which supports reading development and also introduces them ... highly beneficial in promoting learning in the children. ... own dozens of children's picture books and spend approximately ...
... dog' policy and check rising cases of rabies, the police will ... dogs from Nov 16. // ,The campaign aims to ... licence for their dogs, local police said. ,In the ... an increase of 29.69 percent over the same period last year. ...
... most of the flu shot supply had been delivered by ... the state's total order has been received, while the rest ... will be stocked that includes privately purchased flu vaccine. ... Prevention revealed that this flu season over 115 million doses ...
... body's immune system can be used as an effective weapon ... immune system was enhanced by drugs lived longer and their ... in the U.S. were able to improvise the immune system's ... a conference on cancer research at Prague. ,Nearly ...
Cached Medicine News:Health News:Garlic compound may help treat cancer 2Health News:Picture Book Reading Helps Toddlers Grasp Complex Actions 2Health News:New Treatment For Skin Cancer Using Body's own Immune System 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: